Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/ELDN/Capital expenditures

Eledon Pharmaceuticals, Inc. (ELDN) Capital expenditures 2016–2017

Eledon Pharmaceuticals, Inc. (ELDN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$9,000FY2017 · since FY2016: $565,000 → $9,000
1617
Fiscal yearValueYoY
FY2017$9,000-98.4%
FY2016$565,000—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More ELDN financial trends

ELDN RevenueELDN Net incomeELDN Net marginELDN Gross profitELDN Gross marginELDN Operating incomeELDN Operating marginELDN Operating cash flowELDN Free cash flowELDN Return on equityELDN Stock buybacksELDN Dividends paidELDN Total assetsELDN Total liabilitiesELDN Shareholders’ equityELDN overview →